Free Trial
NASDAQ:OBIO

Orchestra BioMed (OBIO) Stock Price, News & Analysis

Orchestra BioMed logo
$2.93 +0.04 (+1.38%)
Closing price 04:00 PM Eastern
Extended Trading
$2.95 +0.02 (+0.68%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Orchestra BioMed Stock (NASDAQ:OBIO)

Key Stats

Today's Range
$2.84
$3.02
50-Day Range
$2.42
$3.38
52-Week Range
$2.37
$8.87
Volume
189,721 shs
Average Volume
187,909 shs
Market Capitalization
$112.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.20
Consensus Rating
Buy

Company Overview

Orchestra BioMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

OBIO MarketRank™: 

Orchestra BioMed scored higher than 53% of companies evaluated by MarketBeat, and ranked 495th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Orchestra BioMed has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Orchestra BioMed has only been the subject of 3 research reports in the past 90 days.

  • Read more about Orchestra BioMed's stock forecast and price target.
  • Earnings Growth

    Earnings for Orchestra BioMed are expected to decrease in the coming year, from ($1.66) to ($1.95) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Orchestra BioMed is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Orchestra BioMed is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Orchestra BioMed has a P/B Ratio of 3.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.96% of the float of Orchestra BioMed has been sold short.
  • Short Interest Ratio / Days to Cover

    Orchestra BioMed has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Orchestra BioMed has recently decreased by 12.40%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Orchestra BioMed does not currently pay a dividend.

  • Dividend Growth

    Orchestra BioMed does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.96% of the float of Orchestra BioMed has been sold short.
  • Short Interest Ratio / Days to Cover

    Orchestra BioMed has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Orchestra BioMed has recently decreased by 12.40%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Orchestra BioMed has a news sentiment score of -0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Orchestra BioMed this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Orchestra BioMed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,183.00 in company stock.

  • Percentage Held by Insiders

    Only 8.10% of the stock of Orchestra BioMed is held by insiders.

  • Percentage Held by Institutions

    53.55% of the stock of Orchestra BioMed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Orchestra BioMed's insider trading history.
Receive OBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orchestra BioMed and its competitors with MarketBeat's FREE daily newsletter.

OBIO Stock News Headlines

$3,200 from your phone?
No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” method, some traders could’ve turned $1,000 into $3,200 — in just 7 days. He’s now revealing this step-by-step strategy for free, and it’s designed to work straight from your phone.
See More Headlines

OBIO Stock Analysis - Frequently Asked Questions

Orchestra BioMed's stock was trading at $4.00 at the beginning of the year. Since then, OBIO stock has decreased by 26.8% and is now trading at $2.93.

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) announced its quarterly earnings data on Monday, May, 12th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.46) by $0.03. The business earned $0.87 million during the quarter, compared to the consensus estimate of $0.39 million. Orchestra BioMed had a negative trailing twelve-month return on equity of 189.26% and a negative net margin of 2,297.85%.

Shares of OBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Orchestra BioMed investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), Meta Platforms (META), Advanced Micro Devices (AMD), NVIDIA (NVDA), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
5/12/2025
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:OBIO
CIK
1814114
Fax
N/A
Employees
4
Year Founded
N/A

Price Target and Rating

High Price Target
$20.00
Low Price Target
$12.00
Potential Upside/Downside
+384.6%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$61.02 million
Net Margins
-2,297.85%
Pretax Margin
-2,297.85%

Debt

Sales & Book Value

Annual Sales
$2.64 million
Price / Cash Flow
N/A
Book Value
$0.87 per share
Price / Book
3.37

Miscellaneous

Free Float
35,210,000
Market Cap
$112.25 million
Optionable
Not Optionable
Beta
0.61
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:OBIO) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners